Concepedia

Yu Yao

YY

Statistics

Publications

56

Citations

3.1K

H-Index

27

Active since

2000

Affiliations

First Affiliated Hospital of Xi'an Jiaotong University(Current)

Peking University

Nanchang University

First Affiliated Hospital of Nanchang University

Chinese Academy of Medical Sciences & Peking Union Medical College

Yu Yao is an author at First Affiliated Hospital of Xi'an Jiaotong University specializing in medicine, oncology, and cancer therapeutics.

ORCID

Top concepts

Publications per year

2000–2024

56

Publications

56

Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Jie Wang, Caicun Zhou, Wenxiu Yao et al. · The Lancet Oncology · 2022 · 361 citations

, , +5

Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients

Yongliang Zhang, Yu Yao, Yaping Xu et al. · Nature Communications · 2021 · 265 citations · Full text

AENEAS: A Randomized Phase III Trial of Aumolertinib Versus Gefitinib as First-Line Therapy for Locally Advanced or MetastaticNon–Small-Cell Lung Cancer With <i>EGFR</i> Exon 19 Deletion or L858R Mutations

Shun Lü, Xiaorong Dong, Hong Jian et al. · Journal of Clinical Oncology · 2022 · 253 citations · Full text

RETRACTED ARTICLE: Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway

Xiao Fu, Mengjie Liu, Shengyang Qu et al. · Journal of Experimental & Clinical Cancer Research · 2018 · 219 citations · Full text

Micro<scp>RNA</scp>‐155‐5p promotes hepatocellular carcinoma progression by suppressing <scp>PTEN</scp> through the <scp>PI</scp>3K/Akt pathway

Xiao Fu, Hongqing Wen, Jing Li et al. · Cancer Science · 2017 · 163 citations · Full text

1–5 of 56